4-ARYLOXYQUINOLIN-2(1H)-ONES AS MTOR KINASE AND PI3 KINASE INHIBITORS, FOR USE AS ANTI-CANCER AGENTS
申请人:Tsou Hwei-Ru
公开号:US20100068204A1
公开(公告)日:2010-03-18
Compounds of the formula I
and pharmaceutically acceptable salts thereof, wherein A, B, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, and R
7
are defined as set forth herein are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier, methods of making the compounds of the invention and methods of using the compounds for inhibiting mTOR and PI3 kinases and for treating cancers.